February, 2003
© 2000, 2001, 2003 Scott S. Emerson, M.D., Ph.D.
“O’Brien-Fleming” stopping rule with desired power
At each interim analysis, stop early if sample mean is
indicated range
At the final analysis, the stopping must occur
N Harm Equiv
Efficacy
26 < -4.01 ---- > 4.09
52 < -2.01
(-0.006,0.006) > 2.01
78 < -1.34
(-0.670,0.670) > 1.34
104
< -1.003 (-1.003,1.003) > 1.023